Logo image of ATEC

ALPHATEC HOLDINGS INC (ATEC) Stock Fundamental Analysis

NASDAQ:ATEC - Nasdaq - US02081G2012 - Common Stock - Currency: USD

14.87  +1.1 (+7.99%)

After market: 14.85 -0.02 (-0.13%)

Fundamental Rating

2

ATEC gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 187 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of ATEC have multiple concerns. While showing a medium growth rate, ATEC is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ATEC has reported negative net income.
ATEC had a negative operating cash flow in the past year.
In the past 5 years ATEC always reported negative net income.
ATEC had a negative operating cash flow in each of the past 5 years.
ATEC Yearly Net Income VS EBIT VS OCF VS FCFATEC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M

1.2 Ratios

ATEC has a Return On Assets (-21.07%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -21.07%
ROE N/A
ROIC N/A
ROA(3y)-24.42%
ROA(5y)-25.75%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ATEC Yearly ROA, ROE, ROICATEC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K -1K

1.3 Margins

ATEC's Gross Margin of 68.96% is fine compared to the rest of the industry. ATEC outperforms 77.54% of its industry peers.
ATEC's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for ATEC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 68.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.25%
GM growth 5Y0.27%
ATEC Yearly Profit, Operating, Gross MarginsATEC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

2

2. Health

2.1 Basic Checks

ATEC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ATEC has about the same amount of shares outstanding.
The number of shares outstanding for ATEC has been increased compared to 5 years ago.
The debt/assets ratio for ATEC is higher compared to a year ago.
ATEC Yearly Shares OutstandingATEC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ATEC Yearly Total Debt VS Total AssetsATEC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of -0.20, we must say that ATEC is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -0.20, ATEC perfoms like the industry average, outperforming 42.78% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.2
ROIC/WACCN/A
WACC7.68%
ATEC Yearly LT Debt VS Equity VS FCFATEC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

ATEC has a Current Ratio of 2.75. This indicates that ATEC is financially healthy and has no problem in meeting its short term obligations.
ATEC has a Current ratio (2.75) which is in line with its industry peers.
ATEC has a Quick Ratio of 1.67. This is a normal value and indicates that ATEC is financially healthy and should not expect problems in meeting its short term obligations.
ATEC has a Quick ratio (1.67) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.75
Quick Ratio 1.67
ATEC Yearly Current Assets VS Current LiabilitesATEC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 24.44% over the past year.
The Revenue has grown by 26.81% in the past year. This is a very strong growth!
Measured over the past years, ATEC shows a very strong growth in Revenue. The Revenue has been growing by 40.08% on average per year.
EPS 1Y (TTM)24.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44.83%
Revenue 1Y (TTM)26.81%
Revenue growth 3Y35.99%
Revenue growth 5Y40.08%
Sales Q2Q%27.46%

3.2 Future

ATEC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.71% yearly.
ATEC is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.92% yearly.
EPS Next Y26.63%
EPS Next 2Y22.71%
EPS Next 3Y24.71%
EPS Next 5YN/A
Revenue Next Year20.8%
Revenue Next 2Y19.57%
Revenue Next 3Y18.91%
Revenue Next 5Y15.92%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ATEC Yearly Revenue VS EstimatesATEC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B
ATEC Yearly EPS VS EstimatesATEC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -0.5 -1 -1.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ATEC. In the last year negative earnings were reported.
Also next year ATEC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ATEC Price Earnings VS Forward Price EarningsATEC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ATEC Per share dataATEC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3 4

4.3 Compensation for Growth

ATEC's earnings are expected to grow with 24.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.71%
EPS Next 3Y24.71%

More info and screens

0

5. Dividend

5.1 Amount

ATEC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALPHATEC HOLDINGS INC

NASDAQ:ATEC (8/4/2025, 8:00:01 PM)

After market: 14.85 -0.02 (-0.13%)

14.87

+1.1 (+7.99%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)07-31 2025-07-31/amc
Earnings (Next)10-28 2025-10-28/amc
Inst Owners63.48%
Inst Owner Change0.08%
Ins Owners9.41%
Ins Owner Change-1.78%
Market Cap2.17B
Analysts81.18
Price Target18.68 (25.62%)
Short Float %11.36%
Short Ratio8.41
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-30.66%
Min EPS beat(2)-45.93%
Max EPS beat(2)-15.38%
EPS beat(4)0
Avg EPS beat(4)-18.52%
Min EPS beat(4)-45.93%
Max EPS beat(4)-3.28%
EPS beat(8)0
Avg EPS beat(8)-24.48%
EPS beat(12)0
Avg EPS beat(12)-22.55%
EPS beat(16)0
Avg EPS beat(16)-29.69%
Revenue beat(2)1
Avg Revenue beat(2)-0.45%
Min Revenue beat(2)-1.38%
Max Revenue beat(2)0.48%
Revenue beat(4)2
Avg Revenue beat(4)-0.44%
Min Revenue beat(4)-1.38%
Max Revenue beat(4)0.48%
Revenue beat(8)6
Avg Revenue beat(8)1.08%
Revenue beat(12)10
Avg Revenue beat(12)2.28%
Revenue beat(16)14
Avg Revenue beat(16)4.27%
PT rev (1m)0%
PT rev (3m)1.53%
EPS NQ rev (1m)0%
EPS NQ rev (3m)6.77%
EPS NY rev (1m)0%
EPS NY rev (3m)-12.97%
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)0.37%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)0.2%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.38
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.02
EYN/A
EPS(NY)-0.56
Fwd EYN/A
FCF(TTM)-0.56
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS4.39
BVpS-0.43
TBVpS-1.57
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -21.07%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 68.96%
FCFM N/A
ROA(3y)-24.42%
ROA(5y)-25.75%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.25%
GM growth 5Y0.27%
F-Score5
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 82.12%
Cap/Sales 11.07%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.75
Quick Ratio 1.67
Altman-Z -0.2
F-Score5
WACC7.68%
ROIC/WACCN/A
Cap/Depr(3y)133.02%
Cap/Depr(5y)167.5%
Cap/Sales(3y)16.62%
Cap/Sales(5y)18.8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44.83%
EPS Next Y26.63%
EPS Next 2Y22.71%
EPS Next 3Y24.71%
EPS Next 5YN/A
Revenue 1Y (TTM)26.81%
Revenue growth 3Y35.99%
Revenue growth 5Y40.08%
Sales Q2Q%27.46%
Revenue Next Year20.8%
Revenue Next 2Y19.57%
Revenue Next 3Y18.91%
Revenue Next 5Y15.92%
EBIT growth 1Y22.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year305.06%
EBIT Next 3Y89.33%
EBIT Next 5Y64.84%
FCF growth 1Y36.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y83.63%
OCF growth 3YN/A
OCF growth 5YN/A